p38-mediated FOXN3 phosphorylation modulates lung inflammation and injury through the NF-κB signaling pathway

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• NF-κB signaling is central to the inflammatory response in methicillin-resistant Staphylococcus aureus (MRSA)-induced lung injury.
• Transcription factors play critical roles in regulating inflammatory pathways.

Purpose of the Study:

• To investigate the role of the Forkhead box transcription factor FOXN3 in MRSA-induced lung inflammation.
• To elucidate the molecular mechanism by which FOXN3 regulates NF-κB signaling in response to MRSA infection.

Main Methods:

• Co-immunoprecipitation assays to study protein-protein interactions (FOXN3, IκBα, hnRNPU, β-TrCP).
• Western blotting to assess protein degradation and phosphorylation (IκBα, FOXN3, p38).
• Analysis of MRSA-induced lung injury in wild-type and genetically modified models (FOXN3 phosphorylation ablation).
• Clinical correlation studies of FOXN3 phosphorylation with pulmonary inflammatory disorders.

Main Results:

• FOXN3 inactivates NF-κB signaling by competing with IκBα for hnRNPU binding, preventing IκBα degradation.
• p38-mediated phosphorylation of FOXN3 at S83/S85 induces its dissociation from hnRNPU, activating NF-κB.
• Phosphorylated FOXN3 undergoes proteasomal degradation; hnRNPU is crucial for this process.
• Genetic ablation of FOXN3 phosphorylation confers resistance to MRSA-induced lung injury.
• FOXN3 phosphorylation levels correlate positively with clinical pulmonary inflammatory disorders.

Conclusions:

• FOXN3 phosphorylation is a critical regulatory mechanism in the inflammatory response to pulmonary MRSA infection.
• Targeting FOXN3 phosphorylation presents a potential therapeutic strategy for MRSA-induced lung inflammation.
• This study reveals a novel pathway involving FOXN3, hnRNPU, and p38 in controlling NF-κB activation during bacterial pneumonia.